StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · AGEN·Healthcare

Agenus Inc. Stock Analysis & AI Score

Agenus Inc. (AGEN) has an ST Score of 60.6 (B), driven by its Forecast (A) and held back by its Financial Strength (C-). Analysts rate it Buy with a $25.00 price target (+194.1% upside).

Market Closed
$8.50
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
61
ST Score
60.6/100B

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

AGEN
60.6out of 100
Grade B

Agenus Inc. (AGEN) has an ST Score of 60.6 (B), driven by its Forecast (A) and held back by its Financial Strength (C-). Analysts rate it Buy with a $25.00 price target (+194.1% upside).

Strongest
ForecastA
Weakest
Financial StrengthC-
All factor grades
  • ForecastA
  • MomentumA-
  • ProfitabilityB
  • GrowthB
  • ValuationC-
  • Financial StrengthC-
  • Piotroski6/9
Score methodology
Press Releases

Contact

AGEN stock: frequently asked questions

What is AGEN's ST Score?

Agenus Inc. (AGEN) has an ST Score of 60.6 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is AGEN a buy, hold, or sell?

Analysts rate AGEN a Buy, with a price target of $25.00 (+194.1% vs the current price). Our ST Score grades it B (60.6/100). The ST Score is a data-driven signal, not a recommendation.

What are AGEN's factor grades?

Valuation C-, Profitability B, Financial Strength C-, Momentum A-, Growth B, Forecast A.

What is AGEN's valuation grade?

Agenus Inc. (AGEN) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is AGEN's growth grade?

Agenus Inc. (AGEN) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is AGEN's profitability grade?

Agenus Inc. (AGEN) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is AGEN's financial strength grade?

Agenus Inc. (AGEN) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for AGEN?

The average analyst price target for Agenus Inc. (AGEN) is $25.00 from 11 analysts, which is +194.1% versus the recent price of $8.50.

What is AGEN's Piotroski score?

Agenus Inc. (AGEN) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.